Cristina Cruz Cortes
Neurology · West Hartford, CTNPI 1427687730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.
Across 92 payments — averaging $39.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Amgen$301
- EMD Serono, Inc.$293
- Teva Pharmaceuticals USA, Inc.$278
- Biogen$265
- AstraZeneca$265
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$211%
- Food & beverage$3,64999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $727 |
| Amgen(2 entities) | 6 | $301 |
| EMD Serono, Inc. | 3 | $293 |
| Teva Pharmaceuticals USA, Inc. | 8 | $278 |
| Biogen | 7 | $265 |
| AstraZeneca | 4 | $265 |
| Novartis | 6 | $257 |
| UCB, Inc. | 4 | $192 |
| NS Pharma, Inc. | 2 | $147 |
| Jazz Pharmaceuticals Inc. | 1 | $128 |
| Sanofi | 2 | $127 |
| Lundbeck LLC | 2 | $113 |
| E.r. Squibb & Sons, L.L.C. | 4 | $94 |
| Pfizer | 3 | $72 |
| PTC Therapeutics, Inc. | 2 | $58 |
| PBG Puerto Rico LLC | 2 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Acadia Pharmaceuticals Inc | 2 | $42 |
| Grifols USA, LLC | 2 | $39 |
| TG Therapeutics, Inc. | 1 | $29 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Impel Pharmaceuticals LLC | 1 | $21 |
| Octapharma USA, Inc. | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,670 in reported general payments places this provider in the 65th percentile of 280 neurology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KeppraLevetiracetam | 24 | $22,565 |
| Tegretol XrCarbamazepine | 12 | $4,917 |
| Dimethyl Fumarate | 12 | $1,918 |
| Naratriptan Hcl | 12 | $473 |
| Topiramate | 16 | $260 |
Paid to pharmacies, not to this prescriber.
Other neurology in West Hartford
- Peter McAllisterFairfield$2.3M
- Stewart TepperStamford$1.2M
- Sharon StollNew Haven$822K
- Mary BaileyNew Haven$630K
- Wanda Castro-BorreroFarmington$553K
- Derek SmithNorwich$469K
- Deena KuruvillaWestport$440K
- Duarte MachadoCheshire$426K
- Tanya BilchikEast Hartford$361K
- Peter GottschalkFairfield$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.